InvestorsObserver
×
News Home

Is ESSA Pharma Inc (EPIX) a Good Choice in Biotechnology Tuesday?

Tuesday, November 28, 2023 01:09 PM | InvestorsObserver Analysts

Mentioned in this article

Is ESSA Pharma Inc (EPIX) a Good Choice in Biotechnology Tuesday?

A rating of 99 puts ESSA Pharma Inc (EPIX) near the top of the Biotechnology industry according to InvestorsObserver. ESSA Pharma Inc's score of 99 means it scores higher than 99% of stocks in the industry. ESSA Pharma Inc also received an overall rating of 86, putting it above 86% of all stocks. Biotechnology is ranked 54 out of the 148 industries.

Overall Score - 86
EPIX has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on EPIX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With ESSA Pharma Inc Stock Today?

ESSA Pharma Inc (EPIX) stock is trading at $5.15 as of 1:05 PM on Tuesday, Nov 28, a decline of -$0.75, or -12.71% from the previous closing price of $5.90. The stock has traded between $5.07 and $5.99 so far today. Volume today is less active than usual. So far 107,622 shares have traded compared to average volume of 304,611 shares. Click Here to get the full Stock Report for ESSA Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App